| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 117, 2547-2549, Copyright © 1985 by Endocrine Society
ARTICLES |
WH Fleming, PR Murphy, LJ Murphy, TW Hatton, RJ Matusik and HG Friesen
The effect of human GH (hGH) on c-myc gene expression and cell proliferation in the Nb2 lymphoma cell line was examined. The addition of hormone to stationary cultures of Nb2 cells resulted in an increased accumulation of c-myc transcripts that was detectable within 15 min, reached a maximum induction of 25-fold in 3 h, and then gradually declined. Although maximal accumulation of c-myc transcripts occurred within 3 h after hGH addition, removal of the hormone even after 4 h of treatment resulted in a failure of the cells to proliferate. This loss of proliferative capacity following hormone removal was accompanied by a 20-fold reduction in the level of c-myc transcripts. These results indicate that hGH induced proliferation of Nb2 cells is associated with the induction and maintenance of c-myc gene expression.
This article has been cited by other articles:
![]() |
A. Giustina, M. Gola, M. Doga, and E. A. Rosei Primary Lymphoma of the Pituitary: An Emerging Clinical Entity J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4567 - 4575. [Full Text] [PDF] |
||||
![]() |
S. Jeay, G. E. Sonenshein, P. A. Kelly, M.-C. Postel-Vinay, and E. Baixeras Growth Hormone Exerts Antiapoptotic and Proliferative Effects through Two Different Pathways Involving Nuclear Factor-{{kappa}}B and Phosphatidylinositol 3-Kinase Endocrinology, January 1, 2001; 142(1): 147 - 156. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |